Oligometastatic breast cancer: old to new entity, outcome and treatment algorithm
Oligometastatic breast cancer: old to new entity, outcome and treatment algorithm
Updates in the diagnostic criteria of serous tubal intraepithelial carcinoma
Post neoadjuvant management in BRCA mutant breast cancer patients
The 2022 OncoAlert Colloquium Day 6: EONS Sessions
The 2022 OncoAlert Colloquium Day 5: GI Oncology
The 2022 OncoAlert Colloquium Day 4: ESGO Sessions and Gynaecological Oncology
The 2022 OncoAlert Colloquium Day 3: Lung Cancer
The 2022 OncoAlert Colloquium Day 2: GU Oncology
The 2022 OncoAlert Colloquium Day 1: Breast Cancer
NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy in locally advanced rectal cancer
Latest in lung cancer genomic testing
10 fundamental health literacy principles for the public to understand when reading health-related articles